These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2109582

  • 1. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
    Szabó I, Barabás J, Tar A, Kiss L, Filep M, Schmidt T, Marossy K, Tóth-Martinez B, Barabás G, Hernádi F.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y, Matsumoto Y, Kaizu M, Fujishita Y, Kojo H.
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [Abstract] [Full Text] [Related]

  • 3. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R.
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [Abstract] [Full Text] [Related]

  • 4. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N, Katsu K, Moriyama M, Kitoh K.
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [Abstract] [Full Text] [Related]

  • 5. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
    Tsuchimori N, Okonogi K.
    J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    Antimicrob Agents Chemother; 1990 May; 34(5):813-8. PubMed ID: 2360820
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M, Sekine Y, Shimizu S, Takano H, Angehrn P, Then RL.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [Abstract] [Full Text] [Related]

  • 8. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins.
    Shigi Y, Kojo H, Wakasugi M, Nishida M.
    Antimicrob Agents Chemother; 1981 Mar; 19(3):393-6. PubMed ID: 7018389
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T, Otani T, Sato M, Ikeuchi T, Osada Y, Ogawa H, Sato K, Mitsuhashi S.
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [Abstract] [Full Text] [Related]

  • 10. [Penicillin-binding proteins. Their enzymatic activity and properties].
    Griaznova NS, Subbotina NA.
    Antibiot Med Biotekhnol; 1986 Jul; 31(7):487-98. PubMed ID: 3532933
    [No Abstract] [Full Text] [Related]

  • 11. [Cefdinir].
    Soejima R.
    Jpn J Antibiot; 1992 Oct; 45(10):1239-52. PubMed ID: 1479675
    [No Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
    Stone GW, Zhang Q, Castillo R, Doppalapudi VR, Bueno AR, Lee JY, Li Q, Sergeeva M, Khambatta G, Georgopapadakou NH.
    Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, Schrinner E.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [Abstract] [Full Text] [Related]

  • 15. Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
    Fontana R, Ligozzi M, Cornaglia G.
    Clin Microbiol Infect; 2000 Jan; 6 Suppl 3():82-3. PubMed ID: 11449662
    [No Abstract] [Full Text] [Related]

  • 16. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R, Altamura M, Arcamone F, Mazzariol A, Morandotti G, Sperning R, Cornaglia G.
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y, Minami S, Hayashi T, Araki H, Kitayama R, Ochiai H.
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
    [Abstract] [Full Text] [Related]

  • 18. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R, Andrews JM, Cross C, Piddock LJ.
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [Abstract] [Full Text] [Related]

  • 19. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T, Retsema J, Girard A, Hamanaka E, Anderson M, Sokolowski S.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.